Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,527,813
+$707,999 QoQ
Shares Held
98,282
+3.7% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#90
of 294 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lumbard & Kellner, LLC holds $2,721,869 across 2 Biotechnology names. DNLI ranks #1 (92.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNLI |
Denali Therapeutics Inc.
This page
|
98,282 | $2,527,813 | |
| 2 | PYPD |
PolyPid Ltd.
|
38,200 | $194,056 |
All Filings in DNLI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,527,813 | 98,282 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,819,814 | 94,782 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||